Bell Investment Advisors »

Allogene Therapeutics shares owned by Bell Investment Advisors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Bell Investment Advisors from 13F filings

Historical chart of Bell Investment Advisors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Bell Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Bell Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $666 486 1.37
2025-09-30 $602 486 1.24
2024-03-31 $719 161 4.47
2023-12-31 $517 161 3.21
2021-09-30 $2.0k 88 22.73

More positions owned by Bell Investment Advisors

Goldman Sachs Etf Tr Acces Treasury (GBIL)
Schwab Strategic Tr Fundamental Us L (FNDX)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Flexshares Tr Iboxx 3r Targt (TDTT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Schwab Strategic Tr Fundamental Intl (FNDF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Msci Usa Mmentm (MTUM)
Schwab Strategic Tr Fundamental Us S (FNDA)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Ishares Core Msci Emkt (IEMG)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Bell Investment Advisors

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Patient Square Capital
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Millennium Management
Two Sigma Investments
Wildcat Capital Management
Two Sigma Advisers
State Street Corporation

View all funds holding Allogene Therapeutics